Not recruiting yet
Clinical Efficacy of Exoskeleton Assistance for Individuals Post-Stroke
NCT06064604 · Georgia Institute of Technology · Updated 26 Nov 2025
- What is being tested
- Control; Hip Exoskeleton; Ankle Exoskeleton
- For
- Stroke
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 85 years. About 20 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 1 Jan 2027, ends 31 Dec 2028. Registered 3 Oct 2023.
- Results
- None posted yet.
In the researchers' words
An exoskeleton device is a robotic system designed to improve an individual's ability to move and perform tasks encountered in everyday situations. These devices consist of external rigid limb segments that assists humans through different body movements with the use of actuators. These devices are controlled by an onboard computer that determines the timing and magnitude of assistance deployed to the user. Exoskeleton controller performance is key to providing beneficial assistance that does not inhibit the user's movement. Preceding work will compare the benefit of personalized hip versus ankle joint exoskeleton assistance for improvement of post-stroke gait. It will combine exoskeleton technology with the user's movement feedback to improve wearable robotic assistance to an individual stroke survivor's gait pattern. For the clinical trial research covered under this protocol, the investigator will test various exoskeleton technologies with stroke survivors in real-world contexts, indoors and outdoors, and measure clinically meaningful outcomes and user perceptions regarding technology usability and adoption. The long-term goal is to deploy self-adaptive, adoptable exoskeletons for personalized assistance during community ambulation.
Sites
- Exoskeleton and Prosthetic Intelligent Controls LabAtlanta, Georgia, United States
